Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...
7月17日，第十九届中国南方血管大会期间，全球介入医学领域企业Cordis康蒂思（以下简称康蒂思）以“桡行股安 动静从容”为主题举办新品上市会，正式发布RADIANZ经桡外周介入整体解决方案与MYNX CONTROL™ ...
Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results